Duration and Safety of Osteoporosis Treatment
-15%
portes grátis
Duration and Safety of Osteoporosis Treatment
Anabolic and Antiresorptive Therapy
Abrahamsen, Bo; Silverman, Stuart
Springer International Publishing AG
01/2016
338
Mole
Inglês
9783319236384
15 a 20 dias
7489
Descrição não disponível.
Foreword Juliet Compston
Preface
Chapter 1 Osteoporosis: Pathophysiology & Epidemiology
Rebecca J. Moon, Cyrus Cooper, and Nicholas C. Harvey
Chapter 2 Antiresorptives
R. Graham G. Russell, Maria K. Tsoumpra, Frank H. Ebetino, Michael Pazianas
Chapter 3 Anabolics
Erik Fink Eriksen
Chapter 4 Tools for Assessing Fracture Risk and for Treatment Monitoring
William D. Leslie, Lisa M. Lix, and Suzanne N. Morin
Chapter 5 Treatment Failure
Elisa Torres del Pliego, Daniel Prieto-Alhambra, and Adolfo Diez-Perez
Chapter 6 Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures
Jeri W. Nieves
Chapter 7 Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features
Joseph C. Giaconi and C. Travis Watterson
Chapter 8 Factors Contributing to Atypical Femoral Fractures
Adele L. Boskey and Marjolein C. H. van der Meulen
Chapter 9 Clinical Presentation of Atypical Femur Fractures
Yelena Bogdan and Thomas A. Einhorn
Chapter 10 Effects of Antiresorptive Therapy on Bone Microarchitecture
Joy N. T
sai and Mary L. Bouxsein
Chapter 11 Management of Atypical Femoral Fractures
Joseph M. Lane, Libi Z. Galmer, David S. Wellman, Abigail L. Campbell, Jonathan E. Jo
Chapter 12 Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features
Parish P. Sedghizadeh and Allan C. Jones
Chapter 13 Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment
Morten Schiodt
Chapter 14 Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment
Morten Schiodt
Chapter 15 Long-Term Efficacy and Safety of Treatments for Osteoporosis
Socrates E. Papapoulos
Chapter 16 Management of Drug Holidays
Christian Roux and Karine Briot
Chapter 17 Patients Who Do Not Take Their Osteoporosis Medications: Can We Help Them Become Compliant?
Deborah T. Gold
Chapter 18 Fractures and Healing on Antiresorptive Therapy
Eli Kupperman and Susan V. Bukata
Chapter 19 Antiresorptive Therapy and Mortality and Cancer Incidence
Peter Vestergaard
Chapter 20 Other Safety Concerns
Michael R. McClung
Chapter 21 The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making
Alexandra Papaioannou, Arnav Agarwal, and Sarah Karampatos
Chapter 22 Integrated Clinical View on Long-Term Management of Patients with Osteoporosis
E. Michael Lewiecki
Chapter 23 Conclusions
Stuart L. Silverman and Bo Abrahamsen
Preface
Chapter 1 Osteoporosis: Pathophysiology & Epidemiology
Rebecca J. Moon, Cyrus Cooper, and Nicholas C. Harvey
Chapter 2 Antiresorptives
R. Graham G. Russell, Maria K. Tsoumpra, Frank H. Ebetino, Michael Pazianas
Chapter 3 Anabolics
Erik Fink Eriksen
Chapter 4 Tools for Assessing Fracture Risk and for Treatment Monitoring
William D. Leslie, Lisa M. Lix, and Suzanne N. Morin
Chapter 5 Treatment Failure
Elisa Torres del Pliego, Daniel Prieto-Alhambra, and Adolfo Diez-Perez
Chapter 6 Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures
Jeri W. Nieves
Chapter 7 Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features
Joseph C. Giaconi and C. Travis Watterson
Chapter 8 Factors Contributing to Atypical Femoral Fractures
Adele L. Boskey and Marjolein C. H. van der Meulen
Chapter 9 Clinical Presentation of Atypical Femur Fractures
Yelena Bogdan and Thomas A. Einhorn
Chapter 10 Effects of Antiresorptive Therapy on Bone Microarchitecture
Joy N. T
sai and Mary L. Bouxsein
Chapter 11 Management of Atypical Femoral Fractures
Joseph M. Lane, Libi Z. Galmer, David S. Wellman, Abigail L. Campbell, Jonathan E. Jo
Chapter 12 Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features
Parish P. Sedghizadeh and Allan C. Jones
Chapter 13 Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment
Morten Schiodt
Chapter 14 Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment
Morten Schiodt
Chapter 15 Long-Term Efficacy and Safety of Treatments for Osteoporosis
Socrates E. Papapoulos
Chapter 16 Management of Drug Holidays
Christian Roux and Karine Briot
Chapter 17 Patients Who Do Not Take Their Osteoporosis Medications: Can We Help Them Become Compliant?
Deborah T. Gold
Chapter 18 Fractures and Healing on Antiresorptive Therapy
Eli Kupperman and Susan V. Bukata
Chapter 19 Antiresorptive Therapy and Mortality and Cancer Incidence
Peter Vestergaard
Chapter 20 Other Safety Concerns
Michael R. McClung
Chapter 21 The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making
Alexandra Papaioannou, Arnav Agarwal, and Sarah Karampatos
Chapter 22 Integrated Clinical View on Long-Term Management of Patients with Osteoporosis
E. Michael Lewiecki
Chapter 23 Conclusions
Stuart L. Silverman and Bo Abrahamsen
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Anabolic therapy;Antiresorptive therapy;Atypical femur fracture;Bisphosphonates;Bone microarchitecture;Drug holiday;Fracture risk assessment;Osteonecrosis of the jaw;Osteoporosis treatment
Foreword Juliet Compston
Preface
Chapter 1 Osteoporosis: Pathophysiology & Epidemiology
Rebecca J. Moon, Cyrus Cooper, and Nicholas C. Harvey
Chapter 2 Antiresorptives
R. Graham G. Russell, Maria K. Tsoumpra, Frank H. Ebetino, Michael Pazianas
Chapter 3 Anabolics
Erik Fink Eriksen
Chapter 4 Tools for Assessing Fracture Risk and for Treatment Monitoring
William D. Leslie, Lisa M. Lix, and Suzanne N. Morin
Chapter 5 Treatment Failure
Elisa Torres del Pliego, Daniel Prieto-Alhambra, and Adolfo Diez-Perez
Chapter 6 Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures
Jeri W. Nieves
Chapter 7 Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features
Joseph C. Giaconi and C. Travis Watterson
Chapter 8 Factors Contributing to Atypical Femoral Fractures
Adele L. Boskey and Marjolein C. H. van der Meulen
Chapter 9 Clinical Presentation of Atypical Femur Fractures
Yelena Bogdan and Thomas A. Einhorn
Chapter 10 Effects of Antiresorptive Therapy on Bone Microarchitecture
Joy N. T
sai and Mary L. Bouxsein
Chapter 11 Management of Atypical Femoral Fractures
Joseph M. Lane, Libi Z. Galmer, David S. Wellman, Abigail L. Campbell, Jonathan E. Jo
Chapter 12 Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features
Parish P. Sedghizadeh and Allan C. Jones
Chapter 13 Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment
Morten Schiodt
Chapter 14 Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment
Morten Schiodt
Chapter 15 Long-Term Efficacy and Safety of Treatments for Osteoporosis
Socrates E. Papapoulos
Chapter 16 Management of Drug Holidays
Christian Roux and Karine Briot
Chapter 17 Patients Who Do Not Take Their Osteoporosis Medications: Can We Help Them Become Compliant?
Deborah T. Gold
Chapter 18 Fractures and Healing on Antiresorptive Therapy
Eli Kupperman and Susan V. Bukata
Chapter 19 Antiresorptive Therapy and Mortality and Cancer Incidence
Peter Vestergaard
Chapter 20 Other Safety Concerns
Michael R. McClung
Chapter 21 The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making
Alexandra Papaioannou, Arnav Agarwal, and Sarah Karampatos
Chapter 22 Integrated Clinical View on Long-Term Management of Patients with Osteoporosis
E. Michael Lewiecki
Chapter 23 Conclusions
Stuart L. Silverman and Bo Abrahamsen
Preface
Chapter 1 Osteoporosis: Pathophysiology & Epidemiology
Rebecca J. Moon, Cyrus Cooper, and Nicholas C. Harvey
Chapter 2 Antiresorptives
R. Graham G. Russell, Maria K. Tsoumpra, Frank H. Ebetino, Michael Pazianas
Chapter 3 Anabolics
Erik Fink Eriksen
Chapter 4 Tools for Assessing Fracture Risk and for Treatment Monitoring
William D. Leslie, Lisa M. Lix, and Suzanne N. Morin
Chapter 5 Treatment Failure
Elisa Torres del Pliego, Daniel Prieto-Alhambra, and Adolfo Diez-Perez
Chapter 6 Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures
Jeri W. Nieves
Chapter 7 Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features
Joseph C. Giaconi and C. Travis Watterson
Chapter 8 Factors Contributing to Atypical Femoral Fractures
Adele L. Boskey and Marjolein C. H. van der Meulen
Chapter 9 Clinical Presentation of Atypical Femur Fractures
Yelena Bogdan and Thomas A. Einhorn
Chapter 10 Effects of Antiresorptive Therapy on Bone Microarchitecture
Joy N. T
sai and Mary L. Bouxsein
Chapter 11 Management of Atypical Femoral Fractures
Joseph M. Lane, Libi Z. Galmer, David S. Wellman, Abigail L. Campbell, Jonathan E. Jo
Chapter 12 Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features
Parish P. Sedghizadeh and Allan C. Jones
Chapter 13 Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment
Morten Schiodt
Chapter 14 Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment
Morten Schiodt
Chapter 15 Long-Term Efficacy and Safety of Treatments for Osteoporosis
Socrates E. Papapoulos
Chapter 16 Management of Drug Holidays
Christian Roux and Karine Briot
Chapter 17 Patients Who Do Not Take Their Osteoporosis Medications: Can We Help Them Become Compliant?
Deborah T. Gold
Chapter 18 Fractures and Healing on Antiresorptive Therapy
Eli Kupperman and Susan V. Bukata
Chapter 19 Antiresorptive Therapy and Mortality and Cancer Incidence
Peter Vestergaard
Chapter 20 Other Safety Concerns
Michael R. McClung
Chapter 21 The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making
Alexandra Papaioannou, Arnav Agarwal, and Sarah Karampatos
Chapter 22 Integrated Clinical View on Long-Term Management of Patients with Osteoporosis
E. Michael Lewiecki
Chapter 23 Conclusions
Stuart L. Silverman and Bo Abrahamsen
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
